SRS Capital Advisors »

Nervgen Pharma Ord shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $68k 18k 3.77

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Intermed (INMU)
Spdr Series Trust State Street Spd (TFI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares Us Thema (THRO)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for SRS Capital Advisors

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
UBS Group
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Busey Trust Company
Sprott
TD Waterhouse Canada
Liberty Wealth Management

View all funds holding Nervgen Pharma Ord